Dec 21, 2024 · However, the discussion of biologics in non-pharyngitis EGID is hampered by a lack of research, necessitating more research in high-quality trials. Keywords: Eosinophilic esophagitis; …

Objective: Eosinophilic esophagitis (EoE) is a chronic, allergen-mediated, eosinophil-predominant, type 2 inflammatory disease that progresses to brostenosis of the esophagus if left untreated. This review …

Mar 27, 2025 · Wondering if you should take a biologic medication to treat eosinophilic esophagitis? Here’s what you should know about this innovative drug class.

ABSTRACT Objective: advancing the understanding of the pathophysiology of eosinophilic oesophagitis (eoe) and other eosinophilic gastrointestinal diseases (eGiDs) has spurred research into targeted …

May 10, 2024 · Over the past 25 years, the incidence of eosinophilic esophagitis (EoE) has risen, making it the second most common esophageal disorder after gastro-esophageal reflux disease.1 …

Feb 25, 2023 · The recent approval of dupilumab for treatment of eosinophilic esophagitis (EOE), research into better biomarkers, and the anticipated availability of a metric to assess EOE severity all …

Dec 21, 2024 · Biologics for eosinophilic oesophagitis: a systematic re view and meta-analysis Beibei Zeng , Doudou Jia b, Shengen Li, Xuna Liu, Boxu Zhu, Yanqi Zhang, Yan Zhuang and Fei Dai

Jun 1, 2021 · Abstract Purpose of review: Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the oesophagus whose incidence is on the rise. Despite maximal use of guideline-based …

Explore the evolution of pharmacologic treatments for eosinophilic esophagitis (EoE), including proton pump inhibitors, topical corticosteroids, and biologic agents, highlighting advancements and future …

Jan 1, 2023 · Eosinophilic esophagitis (EoE) is a chronic, allergen-mediated, eosinophil-predominant, type 2 inflammatory disease that progresses to fibrostenosis of the esophagus if left untreated. This …